STUDY AIM: When children with cancer are no longer curable, parents often need to decide between further aggressive treatments or symptom relief alone. Objectives were to: (1) Describe and compare factors influencing parent and healthcare professional (HCP) decision-making regarding the choice between chemotherapy versus supportive care alone in paediatric palliative care; and (2) Describe how these factors influence this choice. METHODS: Participants included parents of children with cancer without a reasonable chance of cure and health care professionals in paediatric oncology. Respondents were asked to indicate the preferred option and to report what factors affected their choice. Each factor was then rated on an importance visual analogue scale (VAS) ranging from 0 to 10. The importance scales were compared between parents and HCPs and the influence of importance ratings on preferred option was examined. RESULTS: A total of 77 parents and 128 health care professionals participated. For parents the median importance scores for hope, increased survival time and child quality of life were rated as most important (VAS score=10). Parents rated these factors to be significantly more important than HCPs. Conversely, HCPs rated financial considerations more important than parents. For HCPs, stronger importance ranking for parent opinion was associated with stronger preference for aggressive chemotherapy. CONCLUSION: Hope, increased survival time and child quality of life are all more important factors to parents when decision-making at end-of-life compared to HCPs. Conversely, HCPs place greater emphasis on the families' financial considerations than parents. Understanding these differences may aid in communication and improve end-of-life care for children with cancer.
STUDY AIM: When children with cancer are no longer curable, parents often need to decide between further aggressive treatments or symptom relief alone. Objectives were to: (1) Describe and compare factors influencing parent and healthcare professional (HCP) decision-making regarding the choice between chemotherapy versus supportive care alone in paediatric palliative care; and (2) Describe how these factors influence this choice. METHODS:Participants included parents of children with cancer without a reasonable chance of cure and health care professionals in paediatric oncology. Respondents were asked to indicate the preferred option and to report what factors affected their choice. Each factor was then rated on an importance visual analogue scale (VAS) ranging from 0 to 10. The importance scales were compared between parents and HCPs and the influence of importance ratings on preferred option was examined. RESULTS: A total of 77 parents and 128 health care professionals participated. For parents the median importance scores for hope, increased survival time and child quality of life were rated as most important (VAS score=10). Parents rated these factors to be significantly more important than HCPs. Conversely, HCPs rated financial considerations more important than parents. For HCPs, stronger importance ranking for parent opinion was associated with stronger preference for aggressive chemotherapy. CONCLUSION: Hope, increased survival time and child quality of life are all more important factors to parents when decision-making at end-of-life compared to HCPs. Conversely, HCPs place greater emphasis on the families' financial considerations than parents. Understanding these differences may aid in communication and improve end-of-life care for children with cancer.
Authors: Meaghann S Weaver; Katherine E Heinze; Cynthia J Bell; Lori Wiener; Amy M Garee; Katherine P Kelly; Robert L Casey; Anne Watson; Pamela S Hinds Journal: Palliat Med Date: 2015-04-28 Impact factor: 4.762
Authors: Douglas L Hill; Pamela G Nathanson; Karen W Carroll; Theodore E Schall; Victoria A Miller; Chris Feudtner Journal: Pediatrics Date: 2018-04 Impact factor: 7.124
Authors: Jennifer K Walter; Emily Sachs; Theodore E Schall; Aaron G Dewitt; Victoria A Miller; Robert M Arnold; Chris Feudtner Journal: J Pain Symptom Manage Date: 2019-03-12 Impact factor: 3.612
Authors: Chris Feudtner; Jennifer K Walter; Jennifer A Faerber; Douglas L Hill; Karen W Carroll; Cynthia J Mollen; Victoria A Miller; Wynne E Morrison; David Munson; Tammy I Kang; Pamela S Hinds Journal: JAMA Pediatr Date: 2015-01 Impact factor: 16.193
Authors: Amii C Steele; Julia Kaal; Amanda L Thompson; Maru Barrera; Bruce E Compas; Betty Davies; Diane L Fairclough; Terrah L Foster; Mary Jo Gilmer; Nancy Hogan; Kathryn Vannatta; Cynthia A Gerhardt Journal: J Pediatr Hematol Oncol Date: 2013-05 Impact factor: 1.289
Authors: Douglas L Hill; Victoria A Miller; Kari R Hexem; Karen W Carroll; Jennifer A Faerber; Tammy Kang; Chris Feudtner Journal: Health Expect Date: 2013-05-20 Impact factor: 3.377
Authors: Douglas L Hill; Victoria Miller; Jennifer K Walter; Karen W Carroll; Wynne E Morrison; David A Munson; Tammy I Kang; Pamela S Hinds; Chris Feudtner Journal: BMC Palliat Care Date: 2014-03-13 Impact factor: 3.234